Cigna Group Business Summary

The Cigna Group (CI) operates a diversified global health services model, generating revenue through a mix of insurance premiums, pharmacy benefit management (PBM) fees, and specialty pharmacy product sales. The company is structured into two primary segments: Evernorth Health Services, which houses the Express Scripts PBM and high-growth specialty pharmacy units, and Cigna Healthcare, which provides medical insurance and coordinated care solutions to employer, individual, and international markets. Following the 2025 divestiture of its Medicare Advantage business to Health Care Service Corporation (HCSC), Cigna has pivoted toward a service-led, capital-light strategy, with Evernorth now serving as its dominant revenue engine, contributing over 70% of total adjusted earnings. Cigna competes directly with UnitedHealth Group (Optum), CVS Health (Aetna), Elevance Health, and Humana, maintaining its position as the fourth-largest U.S. commercial insurer while leveraging its PBM scale to differentiate through specialty drug management and "cardio-diabesity" clinical programs. Leadership is currently anchored by Chairman and CEO David M. Cordani, a 30-year company veteran who has overseen a 750% increase in shareholder return since 2009; however, the company recently announced that Cordani will transition to Executive Chair on July 1, 2026. He will be succeeded by Brian Evanko, the current President and COO, who brings nearly three decades of internal experience across the CFO and Cigna Healthcare CEO roles. The executive suite is further bolstered by EVP and CFO Ann Dennison, a former CFO of Nasdaq and 20-year Goldman Sachs veteran, and Global CIO Durga Prasad (DP) Koka, who leads the firm's AI and data modernization initiatives. The Board of Directors features high-pedigree members such as Lead Independent Director Eric J. Foss (former CEO of Aramark), George Kurian (CEO of NetApp), and Dr. Mark McClellan (former FDA Commissioner). The company remains heavily backed by institutional giants, with Vanguard Group, BlackRock, and T. Rowe Price holding the largest equity stakes as of early 2026.